{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T09:10:23Z","timestamp":1773306623286,"version":"3.50.1"},"reference-count":14,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2016,2,25]],"date-time":"2016-02-25T00:00:00Z","timestamp":1456358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Circulating microRNAs have been investigated as markers of disease severity in a variety of conditions. We examined whether circulating miR-21 and miR-29a could serve as markers of hepatic fibrosis and disease etiology in children with various liver diseases. Circulating miR-21 and miR-29a were determined in 58 children (21 female, age 0.1\u201317.8 (median 9.8) years)) with chronic liver disease and compared to histological grading of hepatic fibrosis. 22 healthy children served as controls for circulating miRNAs. Levels of circulating miR-21 appeared to be age-dependent in healthy children. Children with biliary atresia had significantly higher levels of miR-21 compared both to healthy controls and to age-matched children with other cholestatic liver disease. Circulating miR-29a levels in biliary atresia children did not differ from healthy controls, but tended to be higher than in age-matched children with other cholestatic liver disease. Neither miR-21 nor miR-29a correlated well with hepatic fibrosis. Circulating miR-21 and miR-29a levels can potentially serve as non-invasive diagnostic markers to differentiate biliary atresia from other cholestatic disease in infancy. They do not appear suitable as non-invasive markers for the degree of hepatic fibrosis in an unselected cohort of children with various liver diseases. The discriminating effect regarding neonatal cholestasis should be followed up in a prospective longitudinal study.<\/jats:p>","DOI":"10.3390\/jcm5030028","type":"journal-article","created":{"date-parts":[[2016,2,25]],"date-time":"2016-02-25T10:24:25Z","timestamp":1456395865000},"page":"28","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Circulating miR-21 and miR-29a as Markers of Disease Severity and Etiology in Cholestatic Pediatric Liver Disease"],"prefix":"10.3390","volume":"5","author":[{"given":"Imeke","family":"Goldschmidt","sequence":"first","affiliation":[{"name":"Department of Paediatric Hepatology and Gastroenterology, Hannover Medical School, Carl-Neuberg-Strasse 1, Hannover 30625, Germany"},{"name":"Integrated Research and Treatment Centre Transplantation (IFB-Tx), Hannover Medical School, Hannover 30625 Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Thum","sequence":"additional","affiliation":[{"name":"Institute for Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Carl-Neuberg-Strasse 1, Hannover 30625, Germany"},{"name":"Integrated Research and Treatment Centre Transplantation (IFB-Tx), Hannover Medical School, Hannover 30625 Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Baumann","sequence":"additional","affiliation":[{"name":"Department of Paediatric Hepatology and Gastroenterology, Hannover Medical School, Carl-Neuberg-Strasse 1, Hannover 30625, Germany"},{"name":"Integrated Research and Treatment Centre Transplantation (IFB-Tx), Hannover Medical School, Hannover 30625 Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2016,2,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.cell.2009.01.035","article-title":"Origins and Mechanisms of miRNAs and siRNAs","volume":"136","author":"Carthew","year":"2009","journal-title":"Cell"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s00395-012-0278-0","article-title":"Role of miR-21 in the pathogenesis of atrial fibrosis","volume":"107","author":"Adam","year":"2012","journal-title":"Basic. Res. Cardiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/hep.23922","article-title":"Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis","volume":"53","author":"Roderburg","year":"2011","journal-title":"Hepatology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.trsl.2011.01.008","article-title":"MicroRNAs and liver disease","volume":"157","author":"Kerr","year":"2011","journal-title":"Transl. Res."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Gilad, S., Meiri, E., Yogev, Y., Benjamin, S., Lebanony, D., and Yerushalmi, N. (2008). Serum microRNAs are promising novel biomarkers. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0003148"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/MPG.0b013e31822200cc","article-title":"Circulating microRNA is a biomarker of pediatric Crohn disease","volume":"53","author":"Zahm","year":"2011","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.taap.2015.02.013","article-title":"Potential of extracellular microRNAs as biomarkers of acetaminophen toxicity in children","volume":"284","author":"Yang","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/MPG.0000000000000600","article-title":"Circulating microRNAs as noninvasive diagnostic biomarkers of liver disease in children with cystic fibrosis","volume":"60","author":"Cook","year":"2015","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1158\/1055-9965.EPI-14-0669","article-title":"Solid tumors of childhood display specific serum microRNA profiles","volume":"24","author":"Murray","year":"2015","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/MPG.0b013e318244148b","article-title":"MicroRNA profiling identifies miR-29 as a regulator of disease-associated pathways in experimental biliary atresia","volume":"54","author":"Hand","year":"2012","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/MPG.0b013e318264e648","article-title":"Circulating microRNA is a biomarker of biliary atresia","volume":"55","author":"Zahm","year":"2012","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s10495-013-0909-4","article-title":"MicroRNA-29a protects against acute liver injury in a mouse model of obstructive jaundice via inhibition of the extrinsic apoptosis pathway","volume":"19","author":"Tiao","year":"2014","journal-title":"Apoptosis"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1161\/ATVBAHA.111.234286","article-title":"Transforming growth factor-beta-induced endothelial-to-mesenchymal transition is partly mediated by microRNA-21","volume":"32","author":"Kumarswamy","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fphys.2012.00049","article-title":"MicroRNA are central players in anti- and profibrotic gene regulation during liver fibrosis","volume":"3","author":"Noetel","year":"2012","journal-title":"Front. Physiol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/5\/3\/28\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:19:41Z","timestamp":1760210381000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/5\/3\/28"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,25]]},"references-count":14,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,3]]}},"alternative-id":["jcm5030028"],"URL":"https:\/\/doi.org\/10.3390\/jcm5030028","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,25]]}}}